Prof Justine Mintern
Professor
Department of Biochemistry and Pharmacology
150 Scholarly works
29 Projects
HIGHLIGHTS
2026
Other
Data from Removal of Interstitial Hyaluronan Facilitates Subcutaneous Administration and Lymphatic Delivery of Anti-CTLA4 and Improves Antitumor Efficacy
DOI: 10.1158/2326-6066.c.83357212026
Other
Figure S7 from Removal of Interstitial Hyaluronan Facilitates Subcutaneous Administration and Lymphatic Delivery of Anti-CTLA4 and Improves Antitumor Efficacy
DOI: 10.1158/2326-6066.314841442026
Other
Figure S6 from Removal of Interstitial Hyaluronan Facilitates Subcutaneous Administration and Lymphatic Delivery of Anti-CTLA4 and Improves Antitumor Efficacy
DOI: 10.1158/2326-6066.314841502026
Other
Figure S4 from Removal of Interstitial Hyaluronan Facilitates Subcutaneous Administration and Lymphatic Delivery of Anti-CTLA4 and Improves Antitumor Efficacy
DOI: 10.1158/2326-6066.314841562025
Research grants (ARC, NHMRC, MRFF)
Enhancing mRNA Vaccines by Exploiting Pathways of Antigen Presentation
2021
Research Grant
Identifying Molecular Machinery in Dendritic Cells.
2019
Research Grant
Novel Tools and Nanotechnology to Navigate Intracellular Trafficking.
RECENT SCHOLARLY WORKS
2026
Other
Figure S2 from Removal of Interstitial Hyaluronan Facilitates Subcutaneous Administration and Lymphatic Delivery of Anti-CTLA4 and Improves Antitumor Efficacy
DOI: 10.1158/2326-6066.314841622026
Other
Figure S12 from Removal of Interstitial Hyaluronan Facilitates Subcutaneous Administration and Lymphatic Delivery of Anti-CTLA4 and Improves Antitumor Efficacy
DOI: 10.1158/2326-6066.314841652026
Other
Figure S8 from Removal of Interstitial Hyaluronan Facilitates Subcutaneous Administration and Lymphatic Delivery of Anti-CTLA4 and Improves Antitumor Efficacy
DOI: 10.1158/2326-6066.314841412026
Other
Figure S11 from Removal of Interstitial Hyaluronan Facilitates Subcutaneous Administration and Lymphatic Delivery of Anti-CTLA4 and Improves Antitumor Efficacy
DOI: 10.1158/2326-6066.314841712026
Other
Figure S1 from Removal of Interstitial Hyaluronan Facilitates Subcutaneous Administration and Lymphatic Delivery of Anti-CTLA4 and Improves Antitumor Efficacy
DOI: 10.1158/2326-6066.314841802026
Other
Figure S10 from Removal of Interstitial Hyaluronan Facilitates Subcutaneous Administration and Lymphatic Delivery of Anti-CTLA4 and Improves Antitumor Efficacy
DOI: 10.1158/2326-6066.31484174
RECENT PROJECTS
2026
Research grants (ARC, NHMRC, MRFF)
Decoding the Epitranscriptome of mRNA Vaccines
2024
Research grants (ARC, NHMRC, MRFF)
National Centre for Biopharmaceutical Optimisation of mRNA Therapeutics